Latest Articles

Publication Date
Characteristics and outcomes of patients with endometriosis and malignant or borderline ovarian tumors: real-world evidence from an ESGO centre of excellence.

Published: April 16, 2026, midnight
Medical and Surgical Management of Endometriosis: A Narrative Review of Clinical Outcomes.

Endometriosis is a chronic, estrogen-dependent, and heterogeneous gynecologic disorder associated with persistent pain, infertility, and substantial impairment in quality of life (QoL), necessitating individualized and evidence-based management. This narrative review …

Published: April 16, 2026, midnight
The efficacy of ultrasound-guided treatment of ovarian endometriosis cysts: A meta-analysis.

The purpose of this meta-analysis was to systematically assess the efficacy of ultrasound-guided therapy of ovarian endometriosis cyst (OEC). Several databases were searched to gather published studies on the efficacy …

Published: April 15, 2026, midnight
REGN5668 Combo Yields Preliminary Activity in Recurrent Ovarian/Endometrial Cancer - CancerNetwork

REGN5668 Combo Yields Preliminary Activity in Recurrent Ovarian/Endometrial Cancer CancerNetwork

Published: April 14, 2026, 8:09 p.m.
A novel magnetic resonance imaging index to evaluate ovarian reserve in endometrioma patients: the ovary to endometrioma volume index.

Ovarian endometrioma is a common form of endometriosis associated with chronic pelvic pain, infertility, and diminished ovarian reserve. Although anti-Müllerian hormone (AMH) is widely used to evaluate ovarian reserve, it …

Published: April 14, 2026, midnight
From Endometriosis to Endometriosis-Associated Ovarian Cancer: Molecular Mechanisms, Risk Stratification and Clinical Implications.

Endometriosis is a chronic estrogen-dependent disorder affecting approximately 10% of women of reproductive age. Increasing epidemiological and molecular evidence indicates that it may represent a precursor condition for a subset …

Published: April 14, 2026, midnight
GSK ovarian and womb cancer drug shows promise in early trial - FemTech World

GSK ovarian and womb cancer drug shows promise in early trial FemTech World

Published: April 13, 2026, 11:05 a.m.
GSK (NYSE: GSK) reports Mo-Rez data in ovarian, endometrial cancer - Stock Titan

GSK (NYSE: GSK) reports Mo-Rez data in ovarian, endometrial cancer Stock Titan

Published: April 13, 2026, 10:23 a.m.
Wonder drug for treating ovarian, womb cancer on the way - NewsBytes

Wonder drug for treating ovarian, womb cancer on the way NewsBytes

Published: April 13, 2026, 6:21 a.m.
GSK posts encouraging data for endometrial and ovarian cancer drug - London South East

GSK posts encouraging data for endometrial and ovarian cancer drug London South East

Published: April 13, 2026, 6 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!